 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
   |
| MJNA Sub HempMeds Mex Exec Invited by United Nations to Speak at WHO Convention |
|
 Hot Stock to Watch |
Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)
|
Last:
Price: 0.0702
Change (%): + 0.0006 (0.86)
Volume: 1,795,418 |
 |
United Nations Invites Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Executive to Speak at World Health Organization Convention in Geneva, Switzerland
Medical Cannabis Advocate and Leader Raúl Elizalde to Speak About CBD on Global Platform
SAN DIEGO, Oct. 26, 2017 /PRNewswire/ - Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® Mexico Executive Raúl Elizalde has been invited to speak on behalf of the family of companies, to the U.N. at the World Health Organization’s (WHO) International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs in Geneva, Switzerland, on Nov. 6, 2017.
Elizalde is a world-renowned medical cannabis advocate who started the Por Grace Foundation to further access to cannabidiol (CBD) by advocating for patients, hosting public forums, and meeting with government officials. Elizalde joined Mexico President Peña Nieto on stage in April, 2016, as the leader announced Mexico’s medical cannabis reform.
At the United Nations’ World Health Organization convention, Elizalde will speak to international leaders about his daughter’s personal experience with CBD and urge organization leaders to not consider CBD psychoactive and not schedule it as a drug. He will also emphasize the importance of the United States’ Ninth Circuit Court ruling that exempted the non-psychoactive parts of the hemp plant from the Controlled Substances Act. Most importantly, Elizalde will present research findings from studies conducted with children using CBD hemp oil products in Mexico by Dr. Saul Garza and Dr. Carlos Aguirre.
“I am honored to be a part of this incredible opportunity to be invited to speak in front of such a prestigious audience on a topic in which I am deeply passionate about,” said HempMeds® Mexico Executive Raúl Elizalde. “I would like to thank my many supporters who continue to aid my journey to further CBD reform worldwide.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
